NCT06986395

Brief Summary

Brief Title: Safe Exercise for Age-Related Muscle Loss in Hospitalized Seniors Summary: This study compares two exercise methods to help older hospital patients (age 65+) rebuild muscle strength after being diagnosed with sarcopenia (age-related muscle loss). We want to know if using special pressure cuffs during light exercise works better than traditional strength training alone. Who Can Join: Hospitalized seniors with stable health conditions Excludes those with severe disabilities, dementia, or certain blood circulation problems What We'll Do: 40 participants will be randomly assigned to either: Traditional Training Group: Uses weights/bands at 65-75% max capacity Arm/leg exercises 3x/week for 4 weeks Pressure Cuff Training Group: Uses special cuffs on arms/thighs during lighter exercises (20% max capacity) Same exercise frequency with controlled pressure for safety What We'll Measure: Handgrip strength (main test at 0/4/12 weeks) Walking speed, balance tests, quality of life surveys Any side effects like dizziness/nausea Safety First: Doctors will check your health before starting. Nurses will monitor every session. We use medical-grade cuffs with safe pressure limits (arm: 80-100mmHg, thigh: 150-200mmHg). You can stop anytime if uncomfortable. Why This Matters: This could help hospitalized seniors regain strength faster using gentler exercises. All activities are supervised by rehabilitation specialists at West China Hospital, with ethics committee approval (IRB number required).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

May 20, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 23, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2025

Completed
Last Updated

May 23, 2025

Status Verified

January 1, 2025

Enrollment Period

4 months

First QC Date

May 20, 2025

Last Update Submit

May 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Handgrip Strength

    Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)

Secondary Outcomes (4)

  • 6-Meter Walking Speed

    Baseline (Week 0), Follow-up (Week 12)

  • Short Physical Performance Battery (SPPB)

    Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)

  • Timed Up and Go Test (TUG)

    Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)

  • MBI

    Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)

Study Arms (2)

BFRT Group

EXPERIMENTAL

"Blood flow restriction training with 20% 1RM loading, pneumatic cuff pressure 80-100mmHg (arms)

Device: Blood Flow Restriction Training (BFRT)

CRT Group

ACTIVE COMPARATOR

Conventional resistance training at 65-75% 1RM intensity using weights/elastic bands, matched frequency/duration

Other: Conventional Resistance Training (CRT)

Interventions

Standard progressive resistance exercise at 65-75% 1RM intensity using weights/elastic bands

BFRT Group

Standard progressive resistance exercise at 65-75% 1RM intensity using weights/elastic bands

CRT Group

Eligibility Criteria

Age65 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Hospitalized patients aged ≥65 years
  • Diagnosed with sarcopenia per EWGSOP2019 criteria
  • Acute medical conditions stabilized for ≥4 weeks (e.g., resolved infections, controlled heart failure)

You may not qualify if:

  • Severe disability (Barthel Index ≤40)
  • Significant cognitive impairment (MMSE ≤18) or major psychiatric disorders (DSM-5 criteria)
  • Contraindications to blood flow restriction training:
  • History/predisposition to deep vein thrombosis
  • Coagulopathy (INR \>1.5, platelets \<100×10⁹/L)
  • Symptomatic varicose veins (CEAP class C4-C6)
  • Uncontrolled hypertension (BP \>160/100 mmHg)
  • Chronic lymphedema (ISL stage II-III)
  • Peripheral artery disease (ABI ≤0.7)
  • Active systemic infection (CRP \>10 mg/L)
  • Malignancy (except non-melanoma skin cancer)
  • Severe renal impairment (eGFR \<30 mL/min/1.73m²)
  • Acute coronary syndrome within 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Blood Flow Restriction Therapy

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist-in-Charge

Study Record Dates

First Submitted

May 20, 2025

First Posted

May 23, 2025

Study Start

May 1, 2025

Primary Completion

September 1, 2025

Study Completion

September 10, 2025

Last Updated

May 23, 2025

Record last verified: 2025-01